Havasu Nutrition

NeuroIGNITE

Serving
1 Capsule(s)
Per container
30
Form
capsule-unknown
UPC
850008464188
DSLD
Formula hash
7ab1aa5c1b96
Brand context
Catalog
72
products
With avoid flag
0
products
FDA recalls
0
history
CAERS
2
reports
Clean labelObjective label signals
Flagged excipients
0
none
FDA recalls
0
no recall history
CAERS reports
1
FDA consumer events
Certifications
0
none recorded
No authority-flagged excipients or recalls. · Every flag below links to the authority's published citation.
NIH LiverTox
1 ingredient with hepatotoxicity classification
Worst severity: Category D
About LiverTox →
  • St. John's WortCategory D

    LiverTox Category D. Few case reports of hepatitis; causality uncertain. Major drug-interaction concern (CYP3A4 induction) — can reduce levels of warfarin, oral contraceptives, immunosuppressants, HIV antivirals.

    LiverTox →

Supplement Facts

7 active ingredients
IngredientAmount% DV
Bacopa Monnieri Extract
BacopaherbUNII · DUB5K84ELI
300 mg
St. John's Wort extract
St. John's WortherbUNII · UFH8805FKA
LiverTox D
130 mg
Dimethylaminoethanol
Deanolherb
50 mg
Ginkgo biloba extract
Ginkgoherb
LiverTox D
50 mg
Phosphatidylserine
otherUNII · 394XK0IH40
50 mg
Acetyl L-Carnitine HCl
Acetyl L-Carnitineherb
50 mg
Huperzine-A
HuperzineherbUNII · 0111871I23
10 mcg
FDA CAERS · adverse event context
1
consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.

CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →

Other ingredients

Gelatin · Magnesium Stearate

Chemically equivalent

Same formula, different brand

Products with identical sorted (ingredient, amount) tuples.